Age-Related Differences in Lower-Limb Muscle Cross-Sectional Area and Torque Production in Boys With Duchenne Muscular Dystrophy

Archives of Physical Medicine and Rehabilitation

Volumn 91, Issue 7, 2010, Pages 1051-1058

  Mathur, Sunita ^a   Lott, Donovan J ^a   Senesac, Claudia ^a   Germain, Sean A ^a   Vohra, Ravneet S ^a   Sweeney, H Lee ^b   Walter, Glenn A ^a   Vandenborne, Krista ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Duchenne; Magnetic resonance imaging; Muscle strength; Muscular dystrophy; Rehabilitation

Indexed keywords

ADOLESCENT; AMBULATORY CARE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUCHENNE MUSCULAR DYSTROPHY; DYNAMOMETRY; GROUPS BY AGE; HUMAN; LEG MUSCLE; MALE; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRESCHOOL CHILD; QUADRICEPS FEMORIS MUSCLE; SCHOOL CHILD; TORQUE; TRICEPS SURAE MUSCLE;

ADOLESCENT; AGE FACTORS; BIOMECHANICS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMAN DEVELOPMENT; HUMANS; ISOMETRIC CONTRACTION; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; TORQUE;

EID: 77953836244     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2010.03.024     Document Type: Article

References (45)

1. Emery A.E. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord 1 (1991) 19-29
2. Deconinck N., and Dan B. Pathophysiology of duchenne muscular dystrophy. Pediatric Neurology 36 (2007) 1-7
3. Petrof B., Shrager J.B., Stedman H.H., Kelly A.M., and Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90 (1993) 3710-3714
4. Sussman M. Duchenne muscular dystrophy. J Amer Acad Orthop Surg 10 (2002) 138-151
5. Marden F.A., Connolly A.M., Siegel M.J., and Rubin D.A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34 (2005) 140-148
6. McDonald C.M., Abresch R.T., Carter G.T., et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 74 5 Suppl (1995) S70-S92
7. Beenakker E.A., Maurits N.M., Fock J.M., Brouwer O.F., and van der Hoeven J.H. Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients. Eur J Paediatr Neurol 9 (2005) 387-393
8. Griggs R.C., Moxley III R.T., Mendell J.R., et al. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol 48 (1991) 383-388
9. Mendell J.R., Moxley R.T., Griggs R.C., et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 320 (1989) 1592-1597
10. Rahman M.M., Hannan M.A., Mondol B.A., Bhoumick N.B., and Haque A. Prednisolone in Duchenne muscular dystrophy. Bangladesh Med Res Counc Bull 27 (2001) 38-42
11. Escolar D.M., Henricson E.K., Mayhew J., et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24 (2001) 787-793
12. Mayhew J.E., Florence J.M., Mayhew T.P., et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve 35 (2007) 36-42
13. Bohannon R.W. Manual muscle testing: does it meet the standards of an adequate screening test?. Clin Rehabil 19 (2005) 662-667
14. Goodpaster B.H., Carlson C.L., Visser M., et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 90 (2001) 2157-2165
15. Skalsky A.J., Han J.J., Abresch R.T., Shin C.S., and McDonald C.M. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve 39 (2009) 647-651
16. Stevens J.E., Walter G.A., Okereke E., et al. Muscle adaptations with immobilization and rehabilitation after ankle fracture. Med Sci Sports Exerc 36 (2004) 1695-1701
17. Gorgey A.S., and Dudley G.A. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 45 (2007) 304-309
18. Shah P.K., Stevens J.E., Gregory C.M., et al. Lower-extremity muscle cross-sectional area after incomplete spinal cord injury. Arch Phys Med Rehabil 87 (2006) 772-778
19. Mathur S., Takai K.P., Macintyre D.L., and Reid D. Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease. Phys Ther 88 (2008) 219-230
20. Trappe T.A., Lindquist D.M., and Carrithers J.A. Muscle-specific atrophy of the quadriceps femoris with aging. J Appl Physiol 90 (2001) 2070-2074
21. Weber M.A., Krakowski-Roosen H., Schroder L., et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol 48 (2009) 116-124
22. Wren T.A., Bluml S., Tseng-Ong L., and Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 190 (2008) W8-W12
23. Gehan E.A., and George S.L. Estimation of human body surface area from height and weight. Cancer Chemother Rep 54 (1970) 225-235
24. Mosteller R.D. Simplified calculation of body-surface area. N Engl J Med 317 (1987) 1098
25. Rosset A., Spadola L., and Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17 (2004) 205-216
26. Vignos Jr. P.J., Spencer Jr. G.E., and Archibald K.C. Management of progressive muscular dystrophy in childhood. JAMA 184 (1963) 89-96
27. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 6 (1979) 65-70
28. Kendall F.P., Kendall E.M., Provance P.C., and Rodger M.M. Muscles: testing and function, with posture and pain. 5th ed. (2005), Lippincott Williams & Wilkins, Baltimore
29. Maganaris C.N. Force-length characteristics of in vivo human skeletal muscle. Acta Physiol Scand 172 (2001) 279-285
30. Manal K., Roberts D.P., and Buchanan T.S. Optimal pennation angle of the primary ankle plantar and dorsiflexors: variations with sex, contraction intensity, and limb. J Appl Biomech 22 (2006) 255-263
31. Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve 36 (2007) 424-435
32. Parreira S.L., Resende M.B., Della Corte Peduto M., Marie S.K., Carvalho M.S., and Reed U.C. Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy. Arq Neuropsiquiatr 65 (2007) 245-250
33. Scott O.M., Hyde S.A., Goddard C., and Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5 (1982) 291-301
34. Jungbluth H., Davis M.R., Muller C., et al. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord 14 (2004) 785-790
35. Kornblum C., Lutterbey G., Bogdanow M., et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 253 (2006) 753-761
36. Mercuri E., Bushby K., Ricci E., et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 15 (2005) 164-171
37. Boesch C. Musculoskeletal spectroscopy. J Magn Reson Imaging 25 (2007) 321-338
38. Kanehisa H., Yata H., Ikegawa S., and Fukunaga T. A cross-sectional study of the size and strength of the lower leg muscles during growth. Eur J Appl Physiol Occup Physiol 72 (1995) 150-156
39. Ramos E., Frontera W.R., Llopart A., and Feliciano D. Muscle strength and hormonal levels in adolescents: gender related differences. Int J Sports Med 19 (1998) 526-531
40. Wood L.E., Dixon S., Grant C., and Armstrong N. Elbow flexion and extension strength relative to body or muscle size in children. Med Sci Sports Exerc 36 (2004) 1977-1984
41. Lai H.C., FitzSimmons S.C., Allen D.B., et al. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med 342 (2000) 851-859
42. Fukunaga T., Roy R.R., Shellock F.G., Hodgson J.A., and Edgerton V.R. Specific tension of human plantar flexors and dorsiflexors. J Appl Physiol 80 (1996) 158-165
43. Uchikawa K., Liu M., Hanayama K., Tsuji T., Fujiwara T., and Chino N. Functional status and muscle strength in people with Duchenne muscular dystrophy living in the community. J Rehabil Med 36 (2004) 124-129
44. Armand S., Mercier M., Watelain E., Patte K., Pelissier J., and Rivier F. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait Posture 21 (2005) 369-378
45. Bakker J., De Groot I.J., Beelen A., and Lankhorst G.J. Predictive factors of cessation of ambulation in patients with Duchenne muscular dystrophy. American Journal of Physical Medicine and Rehabilitation 81 (2002) 906-912